06.04.2016 • News

Teknor Apex Buys Plastic-Technologie-Service

US-based Teknor Apex has acquired Plastic-Technologie-Service (PTS), a German custom compounder of thermoplastic elastomers (TPEs) and engineering thermoplastics (ETPs), for an undisclosed price. The transaction was completed on Mar. 31.

PTS, which has more than 100 employees, contributes a production plant at Steinsfeld, Germany, with a capacity of 20,000 t/y, as well as a technical support facility. A marketing office is also located nearby in Tauberzell.

The company has been making TPE and ETP compounds for Teknor Apex for the past year under a tolling agreement. The two firms have also enjoyed a 15-year relationship involving licensing agreements.

Teknor Apex already compounds TPEs in Genk, Belgium, and produces compounds at its other locations in the US, Singapore and China.

PTS has a diverse portfolio, including block copolymers based on a number of polymer chemistries, thermoplastic vulcanizates (TPVs) and polymer blends. Its ETPs include several types of polyamide as well as polybutylene terephthalate (PBT), PC and PC/ABS blends.

Proprietary specialties include a hard/soft technology for over-molding TPEs onto polar ETP substrates, such as nylon and acetal, and producing a durable bond. Another specialty is radiation-crosslinked grades of ETPs and TPEs.

Jonathan Fain, chairman and CEO of Teknor Apex, said the acquisition is a natural fit with the company’s strategic vision to support the market with a global footprint and local presence.

PTS, as a subsidiary of Teknor Apex, will continue to supply products under its existing brands and its managing director, Uwe Stenglin, will remain in his role.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.